Holen Sie sich die Stockscreener-App
53.70
0.07%
-0.04
Vorhandelsmarkt:
53.40
-0.30
-0.56%
Biomarin Pharmaceutical Inc Aktie (BMRN) Neueste Nachrichten
Inozyme Pharma Acquisition Finalized by BioMarin - Ad-hoc-news.de
BioMarin Pharmaceutical Inc. (BMRN) Outlook Lowered By Leerink - Finviz
BioMarin Pharmaceutical Inc. (BMRN) outlook lowered by Leerink - MSN
Arrowstreet Capital Limited Partnership Raises Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
August 2026 Options Now Available For BioMarin Pharmaceutical (BMRN) - Nasdaq
Jump Financial LLC Grows Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Technical Reactions to BMRN Trends in Macro Strategies - news.stocktradersdaily.com
BioMarin Pharmaceutical Inc. (BMRN): A bull case theory - MSN
Schroder Investment Management Group Trims Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
What margin trends mean for BioMarin Pharmaceutical Inc. stockJuly 2025 Highlights & Free Risk Controlled Daily Trade Plans - Newser
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Dodge & Cox - MarketBeat
Is BioMarin Pharmaceutical Inc. (BM8) stock undervalued historicallyJuly 2025 Catalysts & Low Risk Growth Stock Ideas - Newser
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
BioMarin Pharmaceutical Inc. (BMRN) Stock Forecasts - Yahoo! Finance Canada
BioMarin Pharmaceutical Inc. (BMRN): A Bull Case Theory - Insider Monkey
BioMarin Loses Hormone Patent In Europe - Law360
BioMarin Pharmaceutical (NASDAQ:BMRN) Lowered to "Market Perform" Rating by Leerink Partners - MarketBeat
BioMarin Pharmaceutical (NASDAQ:BMRN) Cut to "Hold" at Leerink Partnrs - MarketBeat
Is BioMarin Pharmaceutical Inc. stock undervalued vs historical averagesJuly 2025 Chart Watch & Advanced Swing Trade Entry Alerts - Newser
Can BioMarin Pharmaceutical Inc. (BM8) stock withstand sector downturns2025 Key Lessons & Technical Pattern Based Signals - Newser
Mackenzie Financial Corp Grows Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
2,043,879 Shares in BioMarin Pharmaceutical Inc. $BMRN Acquired by Norges Bank - MarketBeat
Leerink Partners downgrades BioMarin stock rating to Market Perform By Investing.com - Investing.com South Africa
Uber To Rally Around 43%? Here Are 10 Top Analyst Forecasts For Wednesday - Benzinga
This Wayfair Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday - Benzinga
BMRN Experiences Downgrade and Price Target Cut by Leerink Partn - GuruFocus
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Sio Capital Management LLC - MarketBeat
Leerink Partners downgrades BioMarin stock rating to Market Perform - Investing.com
Leerink Partners Downgrades BioMarin Pharmaceutical to Market Perform From Outperform, Adjusts PT to $60 From $82 - marketscreener.com
Hsbc Holdings PLC Boosts Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Leerink Partners downgrades BioMarin Pharmaceutical (BMRN) - MSN
Korea Investment CORP Raises Stock Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Skandinaviska Enskilda Banken AB publ - MarketBeat
Edgestream Partners L.P. Has $7.12 Million Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Pharma giant BioMarin announces €60m investment in Cork facility - MSN
Quadrature Capital Ltd Purchases New Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Pullback Watch: Is BioMarin Pharmaceutical Inc. stock oversold or undervaluedQuarterly Market Review & Stock Market Timing Techniques - BỘ NỘI VỤ
Icon Advisers Inc. Co. Has $973,000 Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Charles Schwab Investment Management Inc. Grows Stake in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Vinva Investment Management Ltd Has $1.72 Million Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Thornburg Investment Management Inc. Sells 7,417 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Prudential Financial Inc. Boosts Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
BioMarin Pharmaceutical Inc. $BMRN Shares Bought by Rhumbline Advisers - MarketBeat
Is BioMarin Pharmaceutical Inc. stock oversold or undervaluedJuly 2025 Pullbacks & Real-Time Buy Zone Alerts - BỘ NỘI VỤ
BioMarin Pharmaceutical Inc. (BM8.DE) Stock Analysis: Can This Biotech Rebound? - Meyka
Inceptionr LLC Acquires 30,021 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Handelsbanken Fonder AB Sells 7,700 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Rhenman & Partners Asset Management AB Sells 115,350 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Trading the Move, Not the Narrative: (BMRN) Edition - news.stocktradersdaily.com
BioMarin Pharmaceutical (BMRN): Assessing Valuation Following Robust Q3 Growth and Upgraded Full-Year Guidance - Sahm
The Past Three Years for BioMarin Pharmaceutical (NASDAQ:BMRN) Investors Has Not Been Profitable - 富途牛牛
Summit Global Investments Increases Stock Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Will BioMarin’s (BMRN) Raised Outlook After Solid Revenue Growth Shift Its Investment Narrative? - Sahm
Prudential PLC Purchases 24,114 Shares of BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
LSV Asset Management Purchases New Position in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
Nomura Asset Management Co. Ltd. Has $7.95 Million Holdings in BioMarin Pharmaceutical Inc. $BMRN - MarketBeat
AbbVie, Biogen, BioMarin Pharmaceutical, DexCom, and Abbott Laboratories Stocks Trade Up, What You Need To Know - Finviz
Will BioMarin Pharmaceutical Inc. (BM8) stock beat revenue estimatesWeekly Trend Summary & Comprehensive Market Scan Insights - newser.com
0.45%
0.12%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):